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Fifteen serial Burkholderia cepacia complex isolates recovered over a period of 4 years from a single cystic fibrosis patient were analysed
for genomovar status by means of recA sequence determination, and genetic relatedness by RAPD-PCR. Twelve isolates were assigned as
Burkholderia vietnamiensis, two as Burkholderia cenocepacia and one as Burkholderia multivorans. B. vietnamiensis persisted in the
airways during 4 years, except in three occasions when B. cenocepacia or B. multivorans were isolated. The patient was chronically
colonized by B. vietnamiensis with the RAPD-profile 12 and transiently by the RAPD-profile 15.
D 2005 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Burkholderia vietnamiensis; Burkholderia multivorans; Burkholderia cenocepacia; Cystic fibrosis1. Introduction
Bacteria belonging to the Burkholderia cepacia complex
(BCC) are recognized as important opportunistic pathogens
among patients with cystic fibrosis (CF). Multi-drug
resistance, cross-infection due to patient-to-patient trans-
mission or nosocomial spread, and the rapid and unexpected
fatal clinical decline (cepacia syndrome) in some patients
are factors that have pointed to BCC as a major threat to CF
patients [1]. The BCC comprises a number of genomically1569-1993/$ - see front matter D 2005 European Cystic Fibrosis Society. Publish
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1 These authors contributed equally to this work.distinct species. Nine genomovars have been described so
far, and each one has received formal binomial designations,
including B. cepacia (genomovar I), Burkholderia multi-
vorans (genomovar II), Burkholderia cenocepacia
(genomovar III), Burkholderia stabilis (genomovar IV),
Burkholderia vietnamiensis (genomovar V), Burkholderia
dolosa (genomovar VI), Burkholderia ambifaria (genomo-
var VII), Burkholderia anthina (genomovar VIII) and
Burkholderia pyrrocinia (genomovar IX) [2,3].
Although strains from all the genomovars are potentially
capable of causing human infections, differences seem to
exist in their significance in CF patients. B. cenocepacia and
B. multivorans have been described to account for the great
majority of infections in CF [4]. B. cenocepacia appears
more likely to spread from patient to patient, and to be more4 (2005) 267 – 270ed by Elsevier B.V. All rights reserved.
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[5]. Many CF patients have chronic respiratory infection/
colonization by BCC whereas others have transient or
intermittent respiratory infection/colonization [6]. Replace-
ment of one BCC species, such as B. multivorans, B.
vietnamiensis, B. cepacia or B. dolosa, by B. cenocepacia,
with the subsequent deterioration of the patient’s condition,
has been documented in different epidemiological studies
[7,8].
In the present study we assessed the characteristics of
BCC isolates (including four mucoid isolates) recovered
from a CF patient. The microbiological follow-up of the
patient lasted 9 years, but BCC organisms were isolated
over a period of 4 years. The genomovar status and genetic
relatedness of different isolates were determined.2. Material and methods
2.1. Sputum analysis
BCC isolates were obtained from a CF patient attending
the Instituto Fernandes Figueira-FIOCRUZ—a cystic fib-
rosis centre located in Rio de Janeiro, Brazil. Since the CF
diagnosis, the patient (a 13-year-old boy, at that time) was
submitted to a regular multidisciplinary evaluation for 9
years (from November 1989 to November 1999). Thirty-
three sputum samples were obtained through spontaneous
expectoration, during both regular follow-up and exacer-
bation periods. The clinical samples were plated onto sheep
blood agar, Eugon agar, cystine-lactose-electrolyte-deficient
agar and Pseudomonas isolation agar (Difco Labs, Detroit,
MI, USA) supplemented with polymixin B (300 Ag ml- 1)
(Sigma Co., St Louis, MD, USA). Preliminary identification
of different morphotypes, as belonging to the BCC, was
performed by using a panel of conventional phenotypic tests
[9]. The other microorganisms were characterized at the
genus and species level by routine conventional physio-
logical methods [10].
2.2. B. cepacia complex reference strains
Strains BC 1254, BC 788, BC 818, BC 842, BC 825 and
BC 1109, representative of genomovars I, II, IIIA, IIIB, IV,
and V, respectively, were used as reference strains.
Reference strains were kindly provided by Dr. Tyrone Pitt
(Laboratory of Health-Care Associated Infection, Health
Protection Agency, London).
2.3. Genomovar status
In order to identify the distinct genomovars, a 1043 bp
PCR product corresponding to the recA gene was amplified
by PCR using genomic DNA extracted using proteinase K
and phenol as described previously by Sambrook et al. [11]
from the isolates and the reference strains described above.The recA gene was amplified as described by Mahenthir-
alingam et al. (2000) were used [12]. DNA sequence was
performed in both directions with the PCR primers and the
aid of two additional primers, BCR3 and BCR4 [12]. DNA
sequences for each sample were analysed by the Staden
Package [13], and an online CAP3 sequence assembly
program (http://pbil.univ-lyon1.fr/cap3.php). The consensus
sequences obtained were aligned with the ClustalX software
and used to construct phylogenetic trees with the ClustalX
software by the neighbour joining method to allow
genomovar identification [14]. recA reference sequences
for genomovars VI–IX were obtained in GenBank and were
also used for alignment and tree construction.
2.4. Molecular typing
Bacteria were grown overnight at 37 -C in BHI. An
aliquot of the culture was diluted 1:10 in water immediately
before use to determine the optical density at 600 nm.
Cultures were then diluted to a final optical value of 0.5 and
a 300-Al aliquot was centrifuged (13,000g/2 min) and
suspended in 900 Al of sterile distilled water. The
suspension was then boiled for 10 min, briefly centrifuged,
and used as the template source in amplification reaction
[15]. RAPD reaction was carried out with primer 1254
(5VCCGCAGCCAA3V). PCR was performed in 30 Al reaction
volumes containing 20 mM Tris–HCL (pH 8.4), 50 mM
KCl, 3 mM MgCl2, 0,25 mM (each) dNTP (Invitrogen), 30
pmol of primer, 1.5 U of Taq DNA polymerase (Invitrogen)
and 3 Al of bacterial lysate. Cycling parameters for
amplification were as follows: 4 cycles of 94 -C for 5
min, 37- for 5 min, and 72 -C for 5 min, followed by 30
cycles of 94 -C for 1 min, 37 -C for 1 min, and 72 -C for 2
min and a final extension step at 72 -C for 10 min. Reaction
products were analyzed by electrophoresis on 1.2% agarose
gels and stained with 0.5 mg of ethidium bromide per ml.
Gels were photographed under UV light. A 100-bp DNA
ladder (Invitrogen) was used as a molecular weight marker
[16].3. Results
3.1. Genomovar status of the 15 serial isolates
During the first 6 years of the bacteriological follow-up
(November 1989–November 1995), Staphylococcus aur-
eus, non-mucoid and mucoid Pseudomonas aeruginosa
were the only pathogens detected in the sputa. From
December 1995 to September 1997, BCC isolates were
found continuously in association with P. aeruginosa for
two consecutive years. In the last 2 years of evaluation BCC
isolates emerged and persisted chronically as the single
pathogen and, on four occasions, the bacteria exhibited a
mucoid morphotype. DNA sequence analyses of the recA
gene showed that among the 15 BCC isolates examined, 12
Table 1
Characteristics of 15 Burkholderia cepacia complex isolates recovered
from a cystic fibrosis patienta over a follow-up period of 4 years
Isolate Isolation date Morphotype RAPD-profile Speciesb
92 December 1995 Non-mucoid 12 B. vietnamiensis
1116 July 1996 Non-mucoid 12 B. vietnamiensis
1492 May 1997 Non-mucoid 12 B. vietnamiensis
1552 July 1997 Non-mucoid 12 B. vietnamiensis
1637 September 1997 Non-mucoid 12 B. vietnamiensis
1598 October 1997 Non-mucoid 12 B. vietnamiensis
1592 November 1997 Mucoid 13 B. cenocepacia
1639 February 1998 Mucoid 12 B. vietnamiensis
1629 April 1998 Mucoid 12 B. vietnamiensis
1640 June 1998 Mucoid 13 B. cenocepacia
1656 August 1998 Non-mucoid 14 B. multivorans
1663 October 1998 Non-mucoid 12 B. vietnamiensis
1667 November 1998 Non-mucoid 15 B. vietnamiensis
1678 August 1999 Non-mucoid 12 B. vietnamiensis
1685 November 1999 Non-mucoid 12 B. vietnamiensis
a The patient was a 13-year-old boy at the time the first culture was
performed.
b Determined by DNA-sequence of the recA gene.
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genomovar III (B. cenocepacia) and one to genomovar II
(B. multivorans). B. vietnamiensis was found to persist in
the airways during the whole period, except in three
occasions where B. cenocepacia or B. multivorans were
isolated. Among the four isolates exhibiting mucoid
morphotype two (1592 and 1640) were identified as B.
cenocepacia, and two (1629 and 1639) as B. vietnamiensis
(Table 1).
3.2. Genetic relatedness of the B. cepacia complex isolates
All BCC isolates were assayed by a RAPD-PCR in order
to determine their genetic relatedness. Eleven of 12 B.
vietnamiensis isolates exhibited the RAPD profile 12,
whereas one isolate exhibited the profile 15. The B.
multivorans isolate corresponded to the RAPD-profile 14,
whereas the two B cenocepacia isolates corresponded to
RAPD-profile 13 (Fig. 1 and Table 1).Genomovar: V III  V III II V V V
RAPD-PCR profile: 12 13 121212 13 1514 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Fig. 1. RAPD-profiles of Burkholderia cepacia complex species. Lanes—
isolate no.: 1—92; 2—1116; 3—1492; 4—1552; 5—1637; 6—1598; 7—
1592; 8—1639; 9—1629; 10—1640; 11—1656; 12—1663; 13—1667;
14—1678; 15—1685.4. Discussion
We reported the case of a CF patient infected, in several
occasions with B. vietnamiensis and, occasionally, with B.
cenocepacia and B. multivorans, during 4 years. In this
study it was also shown that the B. vietnamiensis isolates
exhibited two different RAPD profiles, 11 isolates exhi-
biting the RAPD profile 12 and, whereas one isolate,
recovered during a limited period (transient infection),
exhibited the profile 15. Strain replacements have already
been described, within the same species or by other species.
These replacements are either transient, as in the present
case, or persistent. The interesting point is that the frequency
of such replacements might be underestimated if all isolatesare not analyzed [8]. In the study published by Bernhardt et
al. [17] isolates recovered from the same patient were
analyzed at intervals of 6 months. It was observed that the
change of the infecting strain was followed by reisolation of
the initial strain type (i.e. strain AYstrain BYstrain A).
This pattern most likely implies co-infection with the
different isolates, although loss of the first strain followed
by reinfection with the primarily infecting strain cannot be
excluded. In the present study, in the course of 1998, 4
different strains were recovered from 6 sputa. Of course, co-
infection with multiple strains cannot be excluded.
B. vietnamiensis , a bacterium commonly used as
promoter of growth in rice crops, infects only a small
number of CF patients, although, in a few patients,
persistent airway infection has been described. However,
little is known about its clinical significance in those
patients [5]. So far, we have no information with regarding
the epidemiology of BCC organisms in the IFF-CF centre
whereas B. vietnamiensis has been reported in another
Brazilian study of infections with BCC organisms in CF and
non-CF patients. In that study, 2 out 11 CF isolates were
assigned as B. vietnamiensis [18]. In addition, a double
infection in a CF Brazilian child involving B. vietnamiensis
and B. cenocepacia has been previously described [19]. In
our study, the four bacterial isolates exhibiting the mucoid
phenotype were identified as B. cenocepacia (1592 and
1640) and B. vietnamiensis (1629 and 1639). Although the
mucoid colony morphotype has been rarely described in
both clinical and environmental isolates of the BCC, recent
studies have also shown that BCC isolates may be
exopolysaccharide (EPS) producers [20,21]. Most of the
persistently infected CF patients monitored by Cunha et al.
[21], harboured mucoid BCC isolates. However, some of the
highest EPS-producing bacteria were obtained from tran-
siently infected patients. Therefore, the role of EPS biosyn-
thesis in the clinical outcome of CF patients and the factors
in the environment of CF patient airways that favour the
transition of BCC from a non-mucoid to a mucoid
phenotype remain to be determined.
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